My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 838

    1.

    T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

    Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.

    Breast Cancer Res. 2009;11(2):R15. Epub 2009 Mar 9.PMID: 19272155 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

    Sunami E, Shinozaki M, Sim MS, Nguyen SL, Vu AT, Giuliano AE, Hoon DS.

    Breast Cancer Res. 2008;10(3):R46. Epub 2008 May 16.PMID: 18485221 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

    Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

    Zentralbl Gynakol. 2006 Apr;128(2):76-81.PMID: 16673249 [PubMed - indexed for MEDLINE]Related articles

    4.

    Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.

    Frogne T, Laenkholm AV, Lyng MB, Henriksen KL, Lykkesfeldt AE.

    Breast Cancer Res. 2009;11(1):R11. Epub 2009 Feb 24.PMID: 19239686 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.

    Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C.

    Genome Biol. 2007;8(8):R157.PMID: 17683518 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.

    Yau C, Benz CC.

    Breast Cancer Res. 2008;10(4):R61. Epub 2008 Jul 17.PMID: 18631401 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

    Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ.

    PLoS One. 2009;4(3):e4710. Epub 2009 Mar 9.PMID: 19270750 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.

    Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H.

    Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21.PMID: 17671124 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.

    Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, Grösch S, Geisslinger G, Holtrich U, Karn T, Kaufmann M.

    Breast Cancer Res Treat. 2008 Nov;112(1):41-52. Epub 2007 Dec 4.PMID: 18058224 [PubMed - indexed for MEDLINE]Related articles

    10.

    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

    Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

    Breast Cancer Res. 2007;9(5):R59.PMID: 17850661 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.

    Webster LR, Lee SF, Ringland C, Morey AL, Hanby AM, Morgan G, Byth K, Mote PA, Provan PJ, Ellis IO, Green AR, Lamoury G, Ravdin P, Clarke CL, Ward RL, Balleine RL, Hawkins NJ.

    Clin Cancer Res. 2008 Oct 15;14(20):6625-33.PMID: 18927304 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

    Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO.

    Clin Cancer Res. 2008 Mar 1;14(5):1368-76.PMID: 18316557 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

    Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

    Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.PMID: 18662380 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome.

    Umemura S, Shirane M, Takekoshi S, Kusakabe T, Itoh J, Egashira N, Tokuda Y, Mori K, Osamura YR.

    Br J Cancer. 2009 Mar 10;100(5):764-71.PMID: 19259095 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.

    Fujii T, Kawahara A, Basaki Y, Hattori S, Nakashima K, Nakano K, Shirouzu K, Kohno K, Yanagawa T, Yamana H, Nishio K, Ono M, Kuwano M, Kage M.

    Cancer Res. 2008 Mar 1;68(5):1504-12.PMID: 18316615 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.

    Calabrò A, Beissbarth T, Kuner R, Stojanov M, Benner A, Asslaber M, Ploner F, Zatloukal K, Samonigg H, Poustka A, Sültmann H.

    Breast Cancer Res Treat. 2009 Jul;116(1):69-77. Epub 2008 Jul 1.PMID: 18592372 [PubMed - indexed for MEDLINE]Related articles

    17.

    Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.

    Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D.

    J Clin Oncol. 2007 Nov 20;25(33):5194-202. Epub 2007 Oct 22.PMID: 17954712 [PubMed - indexed for MEDLINE]Related articles

    18.

    Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.

    Christgen M, Christgen H, Heil C, Krech T, Länger F, Kreipe H, Lehmann U.

    Cancer Sci. 2009 Sep;100(9):1767-71. Epub 2009 May 27.PMID: 19549254 [PubMed - indexed for MEDLINE]Related articles

    19.

    Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.

    Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, Tamaki Y, Terada N, Noguchi S.

    Cancer Sci. 2009 Jun;100(6):1062-8. Epub 2009 Mar 9.PMID: 19385968 [PubMed - indexed for MEDLINE]Related articles

    20.

    Is triple negative a prognostic factor in breast cancer?

    Nishimura R, Arima N.

    Breast Cancer. 2008;15(4):303-8. Epub 2008 Mar 29.PMID: 18369692 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk